|View printer-friendly version|
|May 31, 2010 3:35 p.m.|
|Teva to Present at the UBS Global Specialty Pharmaceuticals Conference|
|Jerusalem, Israel, May 31, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Specialty Pharmaceuticals Conference with Eyal Desheh, Teva's Chief Financial Officer, presenting on Wednesday, June 2, 2010 in London.|
What: Teva's Presentation at the UBS Global Specialty Pharmaceuticals Conference
Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.
When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)
Where: http://cc.talkpoint.com/ubsx001/060210a_ke/?entity=1_IWY155E or http://www.tevapharm.com/financial/
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.